IFX-1-P2.5
| abstract | a randomized, double-blind, double-dummy, active-controlled, multicenter, 2-part Phase 2 study on replacement of steroids by IFX-1 in active granulomatosis with polyangiitis (GPA) and microscopic polyangitis (MPA) |
| type of project | clinical studies |
| status | completed |
| start of project | 2020 |
| end of project | 2021 |
| study design |
This is a prospective, randomized, double-blind, double-dummy,
active-controlled, multicenter, 2-part Phase 2 study. a total of 3
treatment groups will be investigated: Group A: IFX-1 + reduced-dose GC Group B: Placebo-IFX-1 + stadard-dose GC Group C: IFX-1 + no GC |
| responsible person | Dr.Thomas Neumann |